Crystal structures of two I-Ad-peptide complexes reveal that high affinity can be achieved without large anchor residues.

[1]  P Argos,et al.  A comparison of the heme binding pocket in globins and cytochrome b5. , 1975, The Journal of biological chemistry.

[2]  H. Grey,et al.  Antigen recognition by H-2-restricted T cells. II. A tryptic ovalbumin peptide that substitutes for processed antigen. , 1984, Journal of immunology.

[3]  J. Klein.  Natural history of the major histocompatibility complex , 1986 .

[4]  Alessandro Sette,et al.  Structural characteristics of an antigen required for its interaction with Ia and recognition by T cells , 1987, Nature.

[5]  M. A. Saper,et al.  Structure of the human class I histocompatibility antigen, HLA-A2 , 1987, Nature.

[6]  Conrad C. Huang,et al.  The MIDAS display system , 1988 .

[7]  D. Wiley,et al.  A hypothetical model of the foreign antigen binding site of Class II histocompatibility molecules , 1988, Nature.

[8]  H. Grey,et al.  I-Ad-binding peptides derived from unrelated protein antigens share a common structural motif. , 1988, Journal of immunology.

[9]  J. Buerstedde,et al.  A beta polymorphic residues responsible for class II molecule recognition by alloreactive T cells , 1989, The Journal of experimental medicine.

[10]  H. Grey,et al.  Structural analysis of peptides capable of binding to more than one Ia antigen. , 1989, Journal of immunology.

[11]  H. Grey,et al.  Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[12]  A Sette,et al.  Effect of conformational propensity of peptide antigens in their interaction with MHC class II molecules. Failure to document the importance of regular secondary structures. , 1989, Journal of immunology.

[13]  D. Wiley,et al.  Peptide binding to HLA‐DR1: a peptide with most residues substituted to alanine retains MHC binding. , 1990, The EMBO journal.

[14]  J. Sidney,et al.  A novel approach to the generation of high affinity class II-binding peptides. , 1990, Journal of immunology.

[15]  R. Germain,et al.  Cell surface expression of hybrid murine/human MHC class II beta alpha dimers. Key influence of residues in the amino-terminal portion of the beta 1 domain. , 1990, Journal of immunology.

[16]  D. Wiley,et al.  Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. , 1991, Journal of molecular biology.

[17]  A. Taylor,et al.  Identification of eight determinants in the hemagglutinin molecule of influenza virus A/PR/8/34 (H1N1) which are recognized by class II-restricted T cells from BALB/c mice , 1991, Journal of virology.

[18]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[19]  J. Coligan,et al.  Defective intracellular transport as a common mechanism limiting expression of inappropriately paired class II major histocompatibility complex alpha/beta chains , 1991, The Journal of experimental medicine.

[20]  K. Sharp,et al.  Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons , 1991, Proteins.

[21]  T. Watts,et al.  Functional mapping of MHC class II polymorphic residues. The alpha-chain controls the specificity for binding an Ad-versus an A k-restricted peptide and the beta-chain region 65-67 controls T cell recognition but not peptide binding. , 1991, Journal of immunology.

[22]  Axel T. Brunger,et al.  X-PLOR Version 3.1: A System for X-ray Crystallography and NMR , 1992 .

[23]  P. A. Peterson,et al.  Emerging principles for the recognition of peptide antigens by MHC class I molecules. , 1992, Science.

[24]  P. A. Peterson,et al.  Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb. , 1994, Science.

[25]  R. Germain,et al.  MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8 , 1992, Nature.

[26]  A Sette,et al.  Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. , 1992, Science.

[27]  D. Wiley,et al.  Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1 , 1993, Nature.

[28]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[29]  R. Campbell,et al.  MHC genes in autoimmunity. , 1993, Current opinion in immunology.

[30]  T. Yeates,et al.  Verification of protein structures: Patterns of nonbonded atomic interactions , 1993, Protein science : a publication of the Protein Society.

[31]  I. Wilson.  Covalently linked ligand stabilizes expression of heterodimeric receptor. , 1994, Structure.

[32]  P. Bjorkman,et al.  Crystal structure at 2.2 Å resolution of the MHC-related neonatal Fc receptor , 1994, Nature.

[33]  H. Mcdevitt,et al.  A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. , 1994, Immunity.

[34]  P. Cresswell,et al.  Assembly, transport, and function of MHC class II molecules. , 1994, Annual review of immunology.

[35]  Don C. Wiley,et al.  Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide , 1994, Nature.

[36]  J. Navaza,et al.  AMoRe: an automated package for molecular replacement , 1994 .

[37]  P. Marrack,et al.  Production of soluble MHC class II proteins with covalently bound single peptides , 1994, Nature.

[38]  D. Wiley,et al.  Antigenic peptide binding by class I and class II histocompatibility proteins. , 1994, Structure.

[39]  H. Mcconnell,et al.  Formation and dissociation of short-lived class II MHC-peptide complexes. , 1994, Biochemistry.

[40]  J. Rothbard,et al.  Exploration of requirements for peptide binding to HLA DRB1*0101 and DRB1*0401. , 1994, Journal of immunology.

[41]  Partho Ghosh,et al.  The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3 , 1995, Nature.

[42]  A. Rao,et al.  An Ion Pair in Class II Major Histocompatibility Complex Heterodimers Critical for Surface Expression and Peptide Presentation (*) , 1995, The Journal of Biological Chemistry.

[43]  H. Mcdevitt,et al.  Binding of an invariant-chain peptide, CLIP, to I-A major histocompatibility complex class II molecules. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[44]  A Sette,et al.  Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II , 1995, The Journal of experimental medicine.

[45]  J. Cornette,et al.  Molecular analysis of a heteroclitic T cell response to the immunodominant epitope of sperm whale myoglobin. Implications for peptide partial agonists. , 1995, Journal of immunology.

[46]  M. Sanner,et al.  Reduced surface: an efficient way to compute molecular surfaces. , 1996, Biopolymers.

[47]  D. Fremont,et al.  Structures of an MHC Class II Molecule with Covalently Bound Single Peptides , 1996, Science.

[48]  K. Garcia,et al.  Role of chain pairing for the production of functional soluble IA major histocompatibility complex class II molecules , 1996, The Journal of experimental medicine.

[49]  D. Wiley,et al.  Crystallographic analysis of endogenous peptides associated with HLA-DR1 suggests a common, polyproline II-like conformation for bound peptides. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[50]  P. Jensen,et al.  A structural transition in class II major histocompatibility complex proteins at mildly acidic pH , 1996, The Journal of experimental medicine.

[51]  V. Kouskoff,et al.  Organ-Specific Disease Provoked by Systemic Autoimmunity , 1996, Cell.

[52]  E. Unanue,et al.  Amino acid residues on the I-Ak alpha-chain required for the binding and stability of two antigenic peptides. , 1996, Journal of immunology.

[53]  I. Wilson.  Another Twist to MHC-Peptide Recognition , 1996, Science.

[54]  R. Tisch,et al.  Insulin-Dependent Diabetes Mellitus , 1996, Cell.

[55]  C. Ouzounis,et al.  Novel structural features of the human histocompatibility molecules HLA-DQ as revealed by modeling based on the published structure of the related molecule HLA-DR. , 1996, Journal of structural biology.

[56]  L. Stern,et al.  The class II MHC protein HLA-DR1 in complex with an endogenous peptide: implications for the structural basis of the specificity of peptide binding. , 1997, Structure.

[57]  D. Zaller,et al.  X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II. , 1997, Immunity.

[58]  Hans-Georg Rammensee,et al.  MHC Ligands and Peptide Motifs , 1998, Molecular Biology Intelligence Unit.

[59]  P. A. Peterson,et al.  Crystal structure of mouse CD1: An MHC-like fold with a large hydrophobic binding groove. , 1997, Science.

[60]  W A Hendrickson,et al.  Crystal structure of I-Ak in complex with a dominant epitope of lysozyme. , 1998, Immunity.

[61]  P. A. Peterson,et al.  Engineering protein for X‐ray crystallography: The murine major histocompatibility complex class II molecule I‐Ad , 1998, Protein science : a publication of the Protein Society.